Free Review Articles on Stomach (Neoplasia)                                 Metatextbook

Freie Reviews über Magen (Neubildung)                                 Look here for Journal Homepages

  • Stomach (Neoplasia)
  • Enterochromatin like Cell
  • UFT
  • Neoplasia (Inherited)
  • Epstein barr virus
  • Helicobacter pylori
  • Esophagus (Neoplasia)
  • Survivin
  • Neoplasia (Carcinogenesis)
  • Diabetes mellitus T1DM (Type1)
  • Anemia (Pernicious)
  • Gastrin
  • Autoimmune gastritis
  • Autoantibodies Anti Parietal cell
  • Autoantibodies Anti Intrinsic factor
  • PTH (Hyperparathyreoidism BASKET)
  • Mucosectomy
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    11996Pathogenesis and prevention of stomach cancer.



    		+-nlJ Korean Med Sci 11(5):373-85 (1996)
    21996The biological relevance of gastric neuroendocrine tumors.



    		+-nlYale J Biol Med 69(1):69-74 (1996)
    32005Gastric adenocarcinoma: review and considerations for future directions.



    		+-nlAnn Surg 241(1):27-39 (2005)
    41983Gastric carcinoma. A ten-year review.



    		+-nlAnn Surg 198(1):9-12 (1983)
    51964CARCINOMA OF THE STOMACH: REVIEW OF 1,035 CASES.



    		+-nlAnn Surg 159(-):919-32 (1964)
    62004Meta-analysis: the diagnostic value of alarm symptoms for upper gastrointestinal malignancy.



    		+-nlAliment Pharmacol Ther 20(10):1045-52 (2004)
    72004Review article: How useful are the rodent animal models of gastric adenocarcinoma?



    		+-nlAliment Pharmacol Ther 19(8):841-59 (2004)
    82002Review article: intestinal metaplasia and gastric carcinogenesis.



    		+-nlAliment Pharmacol Ther 16(7):1209-16 (2002)
    92002Review article: Pathogenesis of sporadic and familial gastric cancer--implications for clinical management and cancer prevention.



    		+-nlAliment Pharmacol Ther 16(6):1059-66 (2002)
    101999Review article: current perspectives on hypergastrinaemia and enterochromaffin-like-cell hyperplasia.



    		+-nlAliment Pharmacol Ther 13 Suppl 5(-):5-10 (1999)
    112007Chemotherapy for advanced gastric cancer: review of global and Japanese status.



    		+-nlGastrointest Cancer Res 1(5):197-203 (2007)
    122007A short guide to hereditary diffuse gastric cancer.



    		+-nlHered Cancer Clin Pract 5(4):183-94 (2007)
    132005Recent advances in multimodal treatment for gastric cancer: a review.



    		+-nlGastric Cancer 8(2):78-85 (2005)
    142005Current status of surgery for gastric cancer: a review.



    		+-nlGastric Cancer 8(2):64-70 (2005)
    152009Optimising treatment regimens for the management of advanced gastric cancer.



    		+-nlAnn Oncol 20(4):605-8 (2009) Wong R
    162008The treatment of advanced gastric cancer: current strategies and future perspectives.



    		+-nlAnn Oncol 19 Suppl 5(-):v103-7 (2008)
    172008The role of UFT in advanced gastric cancer.



    		+-nlAnn Oncol 19(6):1045-52 (2008)
    182008Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 19 Suppl 2(-):ii23-4 (2008)
    192007Chemoradiotherapy as adjuvant treatment of gastric cancer.



    		+-nlAnn Oncol 18 Suppl 6(-):vi133-5 (2007)
    202007Neo-adjuvant and adjuvant chemotherapy of gastric cancer.



    		+-nlAnn Oncol 18 Suppl 6(-):vi120-3 (2007)
    212006The role of systemic therapy for localised gastric cancer.



    		+-nlAnn Oncol 17 Suppl 10(-):x115-21 (2006)
    222005Adjuvant chemotherapy of gastric cancer: which regimens?



    		+-nlAnn Oncol 16 Suppl 4(-):iv102-105 (2005)
    232003Gastric cancer: epidemiology, pathology and treatment.



    		+-nlAnn Oncol 14 Suppl 2(-):ii31-6 (2003)
    242008Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.



    		+-nlCancer 112(12):2655-63 (2008)
    252007Management of gastroesophageal tumors.



    		+-nlOncologist 12(2):175-85 (2007)
    262008Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features.



    		+-nlCancer Sci 99(2):195-201 (2008)
    272006Genetic factors involved in the development of Helicobacter pylori-related gastric cancer.



    		+-nlCancer Sci 97(11):1129-38 (2006)
    282002Guidelines for the management of oesophageal and gastric cancer.



    		+-nlGut 50 Suppl 5(-):v1-23 (2002)
    291999Gastric epithelial dysplasia.



    		+-nlGut 45(5):784-90 (1999)
    301999Gastric precancerous lesions: heading for an international consensus.



    		+-nlGut 45 Suppl 1(-):I5-8 (1999)
    312008Multidisciplinary management of gastric and gastroesophageal cancers.



    		+-nlWorld J Gastroenterol 14(24):3773-80 (2008)
    322006Assessing risks for gastric cancer: new tools for pathologists.



    		+-nlWorld J Gastroenterol 12(35):5622-7 (2006)
    332006Cellular and molecular aspects of gastric cancer.



    		+-nlWorld J Gastroenterol 12(19):2979-90 (2006)
    342006Role of radiation therapy in gastric adenocarcinoma.



    		+-nlWorld J Gastroenterol 12(10):1511-20 (2006)
    352006Current role of surgical therapy in gastric cancer.



    		+-nlWorld J Gastroenterol 12(3):372-9 (2006)
    362006CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy.



    		+-nlRadiographics 26(1):143-56 (2006)
    372004Scirrhous gastric carcinoma: endoscopy versus upper gastrointestinal radiography.



    		+-nlRadiology 231(2):421-6 (2004)
    382010Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 21 Suppl 5(-):v50-4 (2010)
    392010Multimodality treatment for localized gastro-oesophageal cancer.



    		+-nlAnn Oncol 21 Suppl 7(-):vii286-93 (2010)
    402010New trends for staging and therapy for localized gastroesophageal cancer: the role of PET.



    		+-nlAnn Oncol 21 Suppl 7(-):vii294-9 (2010)
    412009Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 20 Suppl 4(-):34-6 (2009)
    422010Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance.



    		+-nlAnn Surg Oncol 17(1):14-7 (2010)
    432010Pathology of gastric intestinal metaplasia: clinical implications.



    		+-nlAm J Gastroenterol 105(3):493-8 (2010)
    442010Plexiform angiomyxoid myofibroblastic tumor of the stomach.



    		+-nlWorld J Gastroenterol 16(23):2835-40 (2010)
    452011Outcome after endoscopic submucosal dissection for early gastric cancer in Korea.



    		+-nlWorld J Gastroenterol 17(31):3591-5 (2011)
    462011Genomic and genetic alterations influence the progression of gastric cancer.



    		+-nlWorld J Gastroenterol 17(3):290-9 (2011)
    472010Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma.



    		+-nlWorld J Gastroenterol 16(37):4634-9 (2010)
    482007Survivin: potential role in diagnosis, prognosis and targeted therapy of gastric cancer.



    		+-nlWorld J Gastroenterol 13(20):2784-90 (2007)
    492007Carcinosarcoma of the stomach: a case report and review of the literature.



    		+-nlWorld J Gastroenterol 13(41):5533-6 (2007)
    502009Review of salt consumption and stomach cancer risk: epidemiological and biological evidence.



    		+-nlWorld J Gastroenterol 15(18):2204-13 (2009)
    512006Histologic characteristics of gastric polyps in Korea: emphasis on discrepancy between endoscopic forceps biopsy and endoscopic mucosal resection specimen.



    		+-nlWorld J Gastroenterol 12(25):4029-32 (2006)
    522008Cancer of the esophagus and stomach.



    		+-nlMayo Clin Proc 83(6):712-22 (2008)
    532011Animal models to study the role of long-term hypergastrinemia in gastric carcinogenesis.



    		+-nlJ Biomed Biotechnol 2011(-):975479 (2011)
    542008Autoimmune gastritis in type 1 diabetes: a clinically oriented review.



    		+-nlJ Clin Endocrinol Metab 93(2):363-71 (2008)
    552009The syndrome of gastric carcinoid and hyperparathyroidism: a family study and literature review.



    		+-nlEur J Endocrinol 160(4):689-94 (2009)
    562010Role of innate immunity in Helicobacter pylori-induced gastric malignancy.



    		+-nlPhysiol Rev 90(3):831-58 (2010)
    572010Helicobacter pylori and gastric cancer: factors that modulate disease risk.



    		+-nlClin Microbiol Rev 23(4):713-39 (2010)
    582010Predicting response to treatment in gastroesophageal junction adenocarcinomas: combining clinical, imaging, and molecular biomarkers.



    		+-nlOncologist 15(3):270-84 (2010)
    592011Treatment strategies in gastric cancer.



    		+-nlDtsch Arztebl Int 108(41):698-706 (2011)
    602010Capecitabine for the treatment of advanced gastric cancer.



    		+-nlHealth Technol Assess 14(Suppl. 2):11-7 (2010)
    612008Stomach cancer.



    		+-nlClin Evid (Online) 2008(-):- (2008)
    622006Cancer of the stomach.



    		+-nlGastroenterol Clin Biol 30 Spec No 2(-):2S16-2S23 (2006)
    632004Helicobacter pylori and the prevention of gastric cancer.



    		+-nlCan J Gastroenterol 18(5):295-302 (2004)
    642010Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis.



    		+-nlFuture Oncol 6(5):851-62 (2010)
    652006Upper gastrointestinal tumours: diagnosis and staging.



    		+-nlCancer Imaging 6(-):213-7 (2006)
    662004Endoscopic mucosal resection for gastric epithelial neoplasms: a study of 39 cases with emphasis on the evaluation of specimens and recommendations for optimal pathologic analysis.



    		+-nlMod Pathol 17(1):2-8 (2004)
    672004Gastric carcinogenesis.



    		+-nlRev Esp Enferm Dig 96(4):265-76 (2004)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.